| Apretude 600 mg prolonged-release suspension for injection EU/1/23/1760/001 |
Cabotegravir Sodium, cabotegravir |
ViiV Healthcare BV |
— |
| Celsentri 150 mg Film-coated tablet EU/1/07/418/1-5 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 20mg/ ml oral solution EU/01/07/418/013 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 25 mg Film-coated tablet EU/1/07/418/011 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 300 mg Film-coated tablet EU/1/07/418/6-10 |
Maraviroc |
ViiV Healthcare BV |
— |
| Celsentri 75 mg Film-coated tablet EU/1/07/418/012 |
Maraviroc |
ViiV Healthcare BV |
— |
| Combivir 150 mg/300 mg film-coated tablets EU/1/98/058/001 |
Zidovudine, Lamivudine |
ViiV Healthcare BV |
— |
| Combivir 150 mg/300 mg film-coated tablets EU/1/98/058/002 |
Zidovudine, Lamivudine |
ViiV Healthcare BV |
— |
| Dovato 50 mg/300 mg tablets EU/1/19/1370/001-002 |
Dolutegravir sodium, Lamivudine |
ViiV Healthcare BV |
— |
| Epivir 10 mg/ml oral solution EU/1/96/015/002 |
Lamivudine |
ViiV Healthcare BV |
— |
| Epivir 150 mg film-coated tablets EU/1/96/015/001 |
Lamivudine |
ViiV Healthcare BV |
— |
| Epivir 300 mg film-coated tablets EU/1/96/015/003 |
Lamivudine |
ViiV Healthcare BV |
— |
| Juluca 50 mg/25 mg film-coated tablets EU/1/18/1282/001-002 |
Dolutegravir, Rilpivirine hydrochloride, Sodium starch glycolate ep, Iron oxide yellow (E172) |
ViiV Healthcare BV |
— |
| KIVEXA EU/1/04/298/1-2 |
Abacavir sulfate, Lamivudine |
ViiV Healthcare BV |
— |
| Retrovir 10 mg/ml IV concentrate for solution for infusion PA22575/001/003 |
Zidovudine |
ViiV Healthcare BV |
Marketed |
| Retrovir 100 mg capsules, hard PA22575/001/001 |
Zidovudine |
ViiV Healthcare BV |
Marketed |
| Retrovir 100 mg/10 ml oral solution PA22575/001/002 |
Zidovudine |
ViiV Healthcare BV |
Marketed |
| Rukobia 600 mg prolonged-release tablets EU/1/20/1518/001 |
Fostemsavir Tromethamine |
ViiV Healthcare BV |
— |
| Tivicay 10 mg film-coated tablets EU/1/13/892/003-004 |
Dolutegravir |
ViiV Healthcare BV |
— |
| Tivicay 25 mg film-coated tablets EU/1/13/892/005-006 |
Dolutegravir |
ViiV Healthcare BV |
— |
| Tivicay 5 mg dispersible tablets EU/1/13/892/007 |
Dolutegravir sodium |
ViiV Healthcare BV |
— |
| Tivicay 50 mg film-coated tablets EU/1/13/892/001-002 |
Dolutegravir |
ViiV Healthcare BV |
— |
| Triumeq 5 mg/60 mg/30 mg dispersible tablets EU/1/14/940/001-003 |
Dolutegravir sodium, Lamivudine, Abacavir sulfate |
ViiV Healthcare BV |
— |
| Triumeq 50 mg/600 mg/300 mg film-coated tablets EU/1/14/940/001-002 |
Dolutegravir, Abacavir, Lamivudine |
ViiV Healthcare BV |
— |
| Trizivir 300 mg/150 mg/300 mg film-coated tablets EU/1/00/156/002 |
Abacavir sulfate, Zidovudine, Lamivudine |
ViiV Healthcare BV |
— |
| Trizivir 300 mg/150 mg/300 mg film-coated tablets EU/1/00/156/003-4 |
Abacavir sulfate, Zidovudine, Lamivudine |
ViiV Healthcare BV |
— |
| Vocabria 30 mg film-coated tablets EU/1/20/1481/001 |
cabotegravir |
ViiV Healthcare BV |
— |
| Vocabria 400 mg prolonged-release suspension for injection EU/1/20/1481/002 |
cabotegravir |
ViiV Healthcare BV |
— |
| Vocabria 600 mg prolonged-release suspension for injection EU/1/20/1481/003 |
cabotegravir |
ViiV Healthcare BV |
— |
| Ziagen 20mg/mL Oral solution EU/1/99/112/002 |
Abacavir sulfate |
ViiV Healthcare BV |
— |
| Ziagen 300mg Film-coated table EU/1/99/112/001 |
Abacavir sulfate |
ViiV Healthcare BV |
— |